Chatham Rock Phosphate Bilan de santé

Santé financière contrôle des critères 5/6

Chatham Rock Phosphate possède un total de capitaux propres de CA$6.6M et une dette totale de CA$0.0, ce qui porte son ratio d'endettement à 0%. Son actif total et son passif total sont CA$7.0M et de CA$412.2K.

Informations clés

Ratio d'endettement

CA$0

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	CA$167.15k
Fonds propres	CA$6.60m
Total du passif	CA$412.17k
Total des actifs	CA$7.01m

Mises à jour récentes de la santé financière

Recent updates

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de NZP ( CA$243.0K ) ne couvrent pas ses passifs à court terme ( CA$390.2K ).

Passif à long terme: Les actifs à court terme de NZP ( CA$243.0K ) dépassent ses passifs à long terme ( CA$22.0K ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: NZP est sans dette.

Réduire la dette: NZP n'avait aucune dette il y a 5 ans.

Bilan

Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: NZP dispose d'une piste de trésorerie suffisante pour 1 mois sur la base du dernier rapport flux de trésorerie disponible, mais a depuis levé des capitaux supplémentaires.

Prévisions de trésorerie: NZP devrait disposer d'une marge de trésorerie suffisante pour 1 mois sur la base des estimations de flux de trésorerie disponible, mais a depuis levé des capitaux supplémentaires.

Chatham Rock Phosphate Bilan de santé

Santé financière contrôle des critères 5/6

Informations clés

Mises à jour récentes de la santé financière

Chatham Rock Phosphate Limited Auditor Raises 'Going Concern' Doubt

Recent updates

Chatham Rock Phosphate Limited announced that it expects to receive NZD 0.59375 million in funding

Chatham Rock Phosphate Limited, Annual General Meeting, Nov 15, 2024

Chatham Rock Phosphate Limited announced that it has received NZD 0.140556 million in funding

Insufficient new directors

Third quarter 2024 earnings released: CA$0.004 loss per share (vs CA$0.003 loss in 3Q 2023)

Chatham Rock Phosphate Limited announced that it has received CAD 0.436294 million in funding

First half 2024 earnings released: CA$0.011 loss per share (vs CA$0.01 loss in 1H 2023)

Chatham Rock Phosphate Limited announced that it expects to receive CAD 0.7 million in funding

Chatham Rock Phosphate Limited Provides Update on Its Lead Project Korella North

Chatham Rock Phosphate Limited Announces Maiden Mineral Resource Estimate for the Korella North Phosphate Property in Queensland, Australia

New major risk - Revenue and earnings growth

Full year 2023 earnings released: CA$0.021 loss per share (vs CA$0.016 loss in FY 2022)

New minor risk - Shareholder dilution

Chatham Rock Phosphate Limited announced that it has received NZD 0.828591 million in funding

Chatham Rock Phosphate Limited Announces the Korella North Mine Planning and Marketing Advances

Third quarter 2023 earnings released: CA$0.003 loss per share (vs CA$0.006 loss in 3Q 2022)

Chatham Rock Phosphate Limited Announces Work Programme Approve for CRP's Pacific Rare Earths Selenium Exploration Permit At Gunnerside

Chatham Rock Phosphate Limited Grants Pacific Rare Earths Tambo Selenium Exploration Permit

Second quarter 2023 earnings released: CA$0.005 loss per share (vs CA$0.003 loss in 2Q 2022)

Chatham Rock Phosphate Limited Announces Approval from Queensland Department of Resources for Exploration Work in the Tambo Region of Central West Queensland

Chatham Rock Phosphate Limited Advances Korella North Project

Chatham Rock Phosphate Limited Announces Preliminary Phosphate Ore Sorting Results

First quarter 2023 earnings released: CA$0.005 loss per share (vs CA$0.004 loss in 1Q 2022)

Chatham Rock Phosphate Limited Continues to Enlarge Resource Asset Base with New Prospect in Queensland

Chatham Rock Phosphate Limited Applies for Korella North Exploration Permit

Full year 2022 earnings released: CA$0.016 loss per share (vs CA$0.017 loss in FY 2021)

Chatham Rock Phosphate Limited, Annual General Meeting, Nov 17, 2022

Chatham Rock Phosphate Limited Reports Encouraging Dicalcium Phosphate Test Results

Chatham Rock Phosphate Limited Provides Pacific Rare Earths Progress Report

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Chatham Rock Phosphate Limited announced that it has received NZD 0.900125 million in funding from General Research GmbH

First quarter 2022 earnings released: CA$0.004 loss per share (vs CA$0.004 loss in 1Q 2021)

Chatham Rock Phosphate Limited announced that it expects to receive NZD 1.125 million in funding

High number of new directors

Full year 2021 earnings released: CA$0.017 loss per share (vs CA$0.025 loss in FY 2020)

Chatham Rock Phosphate Limited announced that it has received NZD 0.380812 million in funding

Chatham Rock Phosphate Limited (NZSE:CRP) completed the acquisition of Avenir Makatea Pty Ltd.

Chatham Rock Phosphate Limited announced that it has received NZD 0.72 million in funding

Third quarter 2021 earnings released: CA$0.003 loss per share (vs CA$0.005 loss in 3Q 2020)

Chatham Rock Phosphate Limited announced that it has received NZD 0.7 million in funding

Chatham Rock Phosphate Limited (NZSE:CRP) agreed to acquire Avenir Makatea Pty Ltd for CAD 1.5 million.

Chatham Rock Phosphate Limited announced that it expects to receive NZD 0.7 million in funding

Second quarter 2021 earnings released: CA$0.004 loss per share

First quarter earnings released

Chatham Rock Phosphate Limited Auditor Raises 'Going Concern' Doubt

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des pistes de trésorerie

Découvrir des entreprises saines